Skip to main content

Table 5 Cumulative costs per patient short and long term in USD

From: Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital

 

1st Year

5th Year

Paricalcitol

Calcitriol

Paricalcitol

Calcitriol

(A)

(B)

(A)

(B)

SHPT treatment

1,123.44

63.88

2,403

319

Erythropoietin

16,478

19,522.95

82,394

97,615

Intravenous iron

187.76

143.21

939

716

Hospitalization

8,019.41

11,647.99

43,095

62,595

Total

25,809.50

31,378.02

128,831

161,245